SYT13 and cancer: Thus, SYT13 is specifically expressed in primary cancer tissues from such patients, and in a mouse model of peritoneal metastasis, intraperitoneal administration of an SYT13-specific small interfering RNA (siRNA) significantly inhibits the growth of peritoneal nodules and prolongs survival.6